De-escalation of anti-CD20 monoclonal antibodies to low-moderate efficacy disease-modifying treatments (DMTs) in patients with relapse-remitting multiple sclerosis: the initial Ira... by Sepideh Paybast, Nasim Rezaeimanesh, Abdorreza Naser Moghadasi

Get full text

First case of progressive solitary sclerosis with relapsing attacks: A 49‐year‐old woman by Elnaz Asadollahzadeh, Vahid Shahmaei, Zahra Ebadi, Mohammad‐Sadegh Johari, Nasim Rezaeimanesh, Abdorreza Naser Moghadasi

Get full text

Investigating the Correlation Between Cognitive Function and Fasting Blood Sugar, Fasting Insulin Level and Insulin Sensitivity in Patients With Multiple Sclerosis by Nasim Rezaeimanesh, Naghme Abbasi Kasbi, Roghayyeh Saeedi, Mohammad Ali Sahraian, Soodeh Razeghi Jahromi, Abdorreza Naser Moghadasi

Get full text

The impact of social and environmental factors on triggering multiple sclerosis onset, before and during the COVID-19 pandemic: a retrospective study from Iran by Naghmeh Abbasi Kasbi, Fereshteh Ghadiri, Abdorreza Naser Moghadasi, Faezeh Khodaie, Kosar Kohandel, Nasim Rezaeimanesh, Maryam Karaminia, Mohammad Ali Sahraian

Get full text